Philippines Legalizes E-cigarettes in Effort to Reduce Tobacco Harm

Aug.02.2022
The Philippines has passed a law to regulate the import, manufacture, sale, and use of e-cigarettes, aiming to provide safer alternatives for adult smokers.

The Philippines has passed its electronic cigarette bill into law, aimed at regulating the import, manufacture, sale, packaging, distribution, use, and promotion of vaping and heated tobacco products. This legislation makes the Philippines one of the few Asian countries with progressive e-cigarette regulations aimed at benefiting adult smokers.


With this development, the Philippines has joined the ranks of countries such as Thailand, Uruguay, Japan, the United States, and the United Kingdom in adopting progressive regulations supported by scientific evidence to reduce the harm caused by tobacco. The law's most significant aspect is its legalization of electronic cigarettes as a strategy to assist smokers aged 18 and above in choosing less harmful non-combustible alternatives.


Liza Katsiashvili, Community Manager of the World Vapers’ Alliance, said, “While most policymakers have been misled and opposed to e-cigarettes, the Philippines is on the right path by recognizing them as an innovative way to reduce harm and save lives. Other countries should follow this example and support smart e-cigarette policies to ensure improved public health for millions of consumers worldwide.” This transformative development on a global scale provides an important lesson for countries like India to adopt science-based regulations to tackle their smoking problem. India has 12% of the world’s smokers and is the second-largest consumer of tobacco. Despite the numbers increasing, progress in providing harm-reducing alternatives has been limited due to the ban on such products. The country continues to adopt more moral policies by banning harm-reducing alternatives or forcing adult smokers to choose combustible tobacco products through stringent regulations resulting in severe health and economic crises.


As one of the largest emerging economies, India has the opportunity to lead by example and adopt scientifically approved safer alternatives to smoking. However, the country prohibits such alternatives, missing out on a huge opportunity to address the significant public health issue of smoking. Many believe that smoking is a major cause of preventable deaths and illnesses in India.


Extreme policies such as bans are increasingly being questioned in light of scientific evidence indicating that the harm from alternative smoking products is significantly lower than that of traditional cigarettes. Experts and health authorities from around the world, including the Royal College of Physicians and the Public Health England, recognize that smoke-free alternatives represent a revolutionary opportunity to reduce the harm caused by smoking. According to a report by Public Health England entitled "E-cigarettes: Evidence Update," the risk of harm from e-cigarettes is 95% lower than that of regular cigarettes. To avoid missing this important public health opportunity, governments worldwide must re-examine their traditional thinking, challenge moral policies, and strive to provide safer alternatives to achieve tobacco harm reduction's true potential.


This article is compiled from third-party information and is intended solely for industry communication and education purposes.


This article does not represent the views of 2FIRSTS and we cannot confirm the authenticity or accuracy of its contents. The translation of this article is solely for the purpose of industry-related research and exchange.


Due to limitations in the level of translation, the compiled article may not fully express the same message as the original. Please refer to the original article for accuracy.


2FIRSTS maintains complete alignment with the Chinese government on any domestic, Hong Kong, Macau, Taiwan, and foreign-related expressions and positions.


The copyright of the compiled information belongs to the original media and authors. If there is any infringement, please contact us for deletion.



Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

China’s Jiangsu Tobacco Monopoly Bureau and Drug Regulator Target Illegal Vape Sales Disguised as Medical Devices, Define Six Violations
China’s Jiangsu Tobacco Monopoly Bureau and Drug Regulator Target Illegal Vape Sales Disguised as Medical Devices, Define Six Violations
China’s Jiangsu Tobacco Monopoly Bureau and Jiangsu Provincial Medical Products Administration have issued a joint notice targeting illegal production and sales of vape products disguised as medical devices. The notice identifies six categories of violations, including obtaining medical licenses through false materials, misusing medical device credentials, expanding production beyond approved scopes, and using medical device-related online platforms to promote or sell vape products. The action is based on China’s tobacco and medical device regulations and aims to strengthen vape oversight and consumer protection.
Aug.04
Product | ZAR Launches Coffee AirPouch, Expanding Pouch Format Into Caffeine Products
Product | ZAR Launches Coffee AirPouch, Expanding Pouch Format Into Caffeine Products
ZAR has introduced Coffee AirPouch, a nicotine-free caffeine pouch product that extends the brand’s AirPouch format into the functional consumer category. Each pouch contains 50mg of natural caffeine and features a coffee flavor, highlighting how pouch-based products are expanding beyond traditional nicotine applications into broader lifestyle and energy-use scenarios.
Market
Jul.13 by 2Firsts Perspectives
UK Vape Tax Countdown: Retailer Vape HQ Estimates 100ml E-liquid Prices Could Rise From £12.99 to £39.39, While Pod Kits Increase Less Than 10%
UK Vape Tax Countdown: Retailer Vape HQ Estimates 100ml E-liquid Prices Could Rise From £12.99 to £39.39, While Pod Kits Increase Less Than 10%
The UK’s Vaping Products Duty (VPD), scheduled to take effect in October 2026, is prompting retailers to assess how different vape categories may be affected. UK retailer Vape HQ has estimated potential price changes under the new volume-based tax system, showing that 100ml shortfill e-liquids could see prices rise from around £12.99 to £39.39, a 203% increase, while 2ml prefilled pod vape kits could rise from £5.99 to £6.52, an increase of about 9%. The estimates highlight how a volume-based tax structure creates uneven cost impacts across product categories.
Aug.19
China’s Zhengzhou Tobacco Research Institute develops end-to-end heated tobacco analysis to trace aerosol compound origins
China’s Zhengzhou Tobacco Research Institute develops end-to-end heated tobacco analysis to trace aerosol compound origins
The Zhengzhou Tobacco Research Institute of China National Tobacco Corporation has filed a patent application for an end-to-end method to analyze the migration and transformation of chemical compounds in heated tobacco products. Using GC-Orbitrap/MS non-targeted analysis, the method compares tobacco substrate and aerosol samples to distinguish compounds transferred directly from the substrate from those newly formed during heating, while also calculating transfer rates. In an example involving nine heated tobacco products, the patent identified 17 newly formed thermal decomposition compounds and 38 transferred compounds.
Aug.13
Adani’s Mumbai Airport Duty-Free Shops Face Scrutiny Over Nicotine Pouch Sales in India
Adani’s Mumbai Airport Duty-Free Shops Face Scrutiny Over Nicotine Pouch Sales in India
An Indian investigation found that duty-free shops at Mumbai international airport operated by billionaire Gautam Adani’s business group sold nicotine pouches in breach of the law, Reuters reported, in a case that could shape how India regulates sales of new nicotine products at airport retail outlets.
Jul.08
PMI Partners With Italian Tenor Andrea Bocelli to Launch “Believe. Further” Platform
PMI Partners With Italian Tenor Andrea Bocelli to Launch “Believe. Further” Platform
Philip Morris International (PMI) and Italian tenor Andrea Bocelli have launched “Believe. Further,” a multi-year communications platform targeting cultural, institutional and business audiences in Europe, as PMI says smoke-free products accounted for 43% of its net revenues as of the first quarter of 2026.
Jul.01